Drug intelligence / Profile preview

sarmentosin

Development stage
Unknown
Lead developer
Ārepa
Modality
Small Molecules
Administration
Oral
01

Overview

Sarmentosin is a **glycoside** classified as a nitrile glycoside, found in various plants including *Sedum sarmentosum*, *Rhodiola sacra*, and blackcurrant. It has been identified as a bioactive compound with **monoamine oxidase B (MAO-B) inhibitory properties** (IC50 ≈ 2.67 µM) and possible, but less established, inhibition of MAO-A. Sarmentosin shows activity in vitro and in vivo, including a demonstrated capacity to temper MAO-B activity in human subjects after consumption in blackcurrant extract. Additionally, in preclinical studies, sarmentosin induces **autophagy-dependent, caspase-mediated apoptosis** in hepatocellular carcinoma cells via **activation of Nrf2** and inhibition of the **mammalian target of rapamycin (mTOR)** pathway, leading to anti-tumor effects without apparent toxicity to non-tumor tissues. Sarmentosin is found naturally and also used in dietary interventions using blackcurrant extract, and has been tested clinically in small human studies.

Other names
sarmentosinnigrumin(E)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-2-enenitrilesarmentosine
02

Targets

MAOB (Monoamine oxidase B)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)mTOR (Mammalian target of rapamycin kinase)MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on sarmentosin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sarmentosin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call